Table of Contents Table of Contents
Previous Page  179 / 1082 Next Page
Information
Show Menu
Previous Page 179 / 1082 Next Page
Page Background

S166

ESTRO 36 2017

_______________________________________________________________________________________________

may lead to better palliation and possibly increase survival

with the advantage of a short overall treatment time. The

superior soft tissue contrast of MRI might improve tumour

contouring and MRI is capable of tumour motion

quantification. We want to investigate the technical

feasibility and safety of MRI-guided SBRT for LAPC.

Material and Methods

From July 2013 to January 2016, 20 patients with LAPC or

medically unresectable pancreatic cancer without distant

metastasis were included in this study (Table). A custom

made abdominal corset was manufactured to reduce

breathing induced tumour motion. Contouring of the gross

tumour volume (GTV) and organs at risk (OARs) was

performed on 4D treatment planning CT and

multiparametric MRI. A GTV-to-PTV margin of 3 mm was

applied. We quantified tumour motion with cine MRI. After

treatment planning, the static dose distribution was

convolved with the cine MRI based motion trajectory to

simulate and evaluate the delivered dose to the GTV, PTV,

and OARs. SBRT was carried out up to a dose of 24 Gray in

3 fractions in one week. Online position verification was

performed with 4D CBCTs, with 4D matching based on gold

fiducial markers at the midventilation position.

Results

All patients underwent uncomplicated endoscopic fiducial

marker placement. Tumours and OARS were clearly visible

with contrast enhanced CT and multiparametric MRI

(Figure). On the 4D planning CT and on the 4D CBCT scans,

the fiducial markers were clearly visible. The corset

decreased peak-to-peak tumour motion in craniocaudal

direction on average from 11.3 to 7.2 mm. With

incorporation of the tumour motion trajectory, the dose

distribution was blurred and, in this way, the actual

delivered dose was simulated. In all patients, an adequate

dose distribution was achieved with acceptable dose in the

OARs (Table). Position verification based on 4D marker

matching was feasible. No grade 3 or higher treatment

related toxicity was observed in these patients to date.

Figure: Contouring with the aid of MRI and CT. Red: GTV.

Green: pancreatic head. Blue: duodenum.